Free Trial
Ends Tomorrow! Last Chance to Get MarketBeat All Access at $149
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Lock In $149
Claim MarketBeat All Access Sale Promotion

The Ensign Group (NASDAQ:ENSG) Stock Price Crosses Above 200 Day Moving Average - What's Next?

The Ensign Group logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Ensign shares rose above their 200-day moving average, trading as high as $187.25 versus the $181.50 average, amid an 8.6% gain.
  • The company reported third-quarter adjusted EPS of $2.03, beating estimates, while revenue grew 14.5% year over year to $1.48 billion but fell slightly short of forecasts. Ensign also raised its 2026 earnings guidance.
  • Analysts maintain a generally favorable outlook, with a “Moderate Buy” consensus and a $216.25 average price target, though a securities class-action lawsuit creates legal, regulatory and reputational risks.
  • MarketBeat previews the top five stocks to own by November 1st.

The Ensign Group, Inc. (NASDAQ:ENSG - Get Free Report) passed above its two hundred day moving average during trading on Wednesday. The stock has a two hundred day moving average of $181.50 and traded as high as $187.25. The Ensign Group shares last traded at $184.11, with a volume of 974,029 shares.

The Ensign Group News Roundup

Here are the key news stories impacting The Ensign Group this week:

  • Positive Sentiment: Ensign reported third-quarter adjusted earnings of $2.03 per share, above analyst estimates of roughly $1.94–$1.97 and up from $1.64 a year earlier. Revenue increased 14.5% year over year to $1.48 billion, demonstrating continued operating growth despite falling modestly short of the $1.51 billion consensus estimate. The Ensign Group Reports Third Quarter 2026 Results
  • Positive Sentiment: The company raised its 2026 annual earnings guidance, signaling management confidence in ongoing demand, operating execution and earnings growth. UBS analyst A.J. Rice reiterated a Buy rating, citing strong operating trends and the upgraded outlook. UBS Reiterates Buy on Ensign
  • Neutral Sentiment: While the earnings beat was favorable, the revenue miss may limit the bullish reaction and suggests investors will watch the company’s pace of growth and execution closely. Ensign Reports Sales Below Estimates
  • Negative Sentiment: Several law firms publicized a securities class action involving Ensign and its executives. The allegations, which have not been proven, relate to claims that the company concealed patient neglect, understaffing, manipulated quality or staffing data, improper billing and an administrator-license rental arrangement following a short-seller report. Investors who purchased shares between February 10, 2022, and June 18, 2026, face a December 7, 2026 lead-plaintiff deadline. The litigation could increase costs, regulatory scrutiny and reputational risk. Ensign Investor Class Action Filed

Wall Street Analysts Forecast Growth

ENSG has been the subject of a number of research reports. Royal Bank Of Canada reiterated an "outperform" rating and set a $228.00 target price on shares of The Ensign Group in a report on Tuesday, July 28th. Truist Financial boosted their price target on The Ensign Group from $202.00 to $207.00 and gave the company a "hold" rating in a report on Thursday, July 30th. Weiss Ratings raised The Ensign Group from a "buy (b-)" rating to a "buy (b)" rating in a research report on Thursday, October 8th. Finally, Wall Street Zen upgraded The Ensign Group from a "hold" rating to a "buy" rating in a report on Sunday. Four investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $216.25.

Read Our Latest Analysis on The Ensign Group

The Ensign Group Trading Up 8.6%

The company has a quick ratio of 1.21, a current ratio of 1.21 and a debt-to-equity ratio of 0.06. The stock has a market cap of $10.73 billion, a price-to-earnings ratio of 28.86, a PEG ratio of 1.66 and a beta of 0.66. The business's 50 day simple moving average is $174.68 and its 200 day simple moving average is $181.50.

The Ensign Group (NASDAQ:ENSG - Get Free Report) last issued its quarterly earnings data on Tuesday, October 27th. The company reported $2.03 earnings per share for the quarter, beating the consensus estimate of $1.97 by $0.06. The Ensign Group had a net margin of 6.90% and a return on equity of 16.75%. The company had revenue of $1.48 billion for the quarter, compared to analyst estimates of $1.51 billion. During the same period in the prior year, the firm earned $1.64 earnings per share. The company's revenue was up 14.5% on a year-over-year basis. On average, research analysts expect that The Ensign Group, Inc. will post 7.04 EPS for the current fiscal year.

The Ensign Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Saturday, October 31st. Investors of record on Wednesday, September 30th will be paid a $0.0650 dividend. This represents a $0.26 annualized dividend and a dividend yield of 0.1%. The ex-dividend date is Wednesday, September 30th. The Ensign Group's payout ratio is 4.08%.

Institutional Investors Weigh In On The Ensign Group

A number of large investors have recently added to or reduced their stakes in ENSG. Transamerica Financial Advisors LLC bought a new position in shares of The Ensign Group during the second quarter valued at about $26,000. Caitlin John LLC purchased a new position in shares of The Ensign Group in the second quarter valued at about $31,000. Cedar Mountain Advisors LLC bought a new position in shares of The Ensign Group during the first quarter valued at about $32,000. Northwestern Mutual Wealth Management Co. bought a new position in shares of The Ensign Group during the second quarter valued at about $33,000. Finally, Continuum Advisory LLC purchased a new stake in shares of The Ensign Group during the second quarter worth about $34,000. Institutional investors and hedge funds own 96.12% of the company's stock.

About The Ensign Group

(Get Free Report)

The Ensign Group, Inc is a healthcare services company that provides skilled nursing, post-acute care and rehabilitation services. Its facilities serve patients recovering from illness, injury or surgery, as well as individuals requiring long-term nursing care and support with daily living.

Through its operating subsidiaries, Ensign also provides assisted living and other senior care services. Its portfolio includes skilled nursing facilities, senior living communities and related healthcare operations, with services such as physical, occupational and speech therapy, medically complex care and rehabilitation.

Founded in 1999 and headquartered in San Juan Capistrano, California, The Ensign Group operates healthcare facilities across multiple U.S.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in The Ensign Group Right Now?

Before you consider The Ensign Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Ensign Group wasn't on the list.

While The Ensign Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own in Fall 2026 Cover

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines